Soleno Therapeutics Depreciation & Amortization 2011-2026 | SLNO

Annual Depreciation & Amortization Soleno Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
2.02 M	1.99 M	1.96 M	1.96 M	1.96 M	1.95 M	1.96 M	1.96 M	1.61 M	18.7 K	108 K	28.5 K	42.1 K	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
2.02 M	18.7 K	1.35 M

Quarterly Depreciation & Amortization Soleno Therapeutics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
502 K	502 K	504 K	-	500 K	494 K	490 K	-	-	-	490 K	-	1.48 M	984 K	492 K	-	1.47 M	979 K	489 K	-	1.47 M	977 K	489 K	-	1.47 M	978 K	489 K	-	1.47 M	983 K	492 K	-	1.03 M	570 K	119 K	-	1 K	45 K	20 K	-	59 K	31 K	15 K	-	20 K	14 K	7 K	-	32 K	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.48 M	1 K	576 K

Depreciation & Amortization of other stocks in the Diagnostics research industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Akumin AKU	98.2 M	-	-17.87 %	$ 25.9 M	Canada
Agilent Technologies A	321 M	$ 115.55	1.0 %	$ 35.1 B	USA
Accelerate Diagnostics AXDX	1.7 M	-	-61.36 %	$ 2.46 M	USA
Aspira Women's Health AWH	112 K	-	-6.19 %	$ 10.5 M	USA
Biocept BIOC	1.66 M	-	-13.05 %	$ 7.29 M	USA
Check-Cap Ltd. CHEK	161 K	-	-	$ 9.42 M	Israel
Chembio Diagnostics CEMI	2.55 M	-	0.22 %	$ 16.8 M	USA
Co-Diagnostics CODX	1.11 M	$ 1.67	-2.34 %	$ 2.22 M	USA
Castle Biosciences CSTL	16 M	$ 24.46	3.25 %	$ 679 M	USA
CareDx, Inc CDNA	15 M	$ 21.23	5.83 %	$ 1.13 B	USA
DermTech DMTK	200 K	-	-11.32 %	$ 2.94 M	USA
Lantheus Holdings LNTH	70.1 M	$ 84.33	1.82 %	$ 5.69 B	USA
Enzo Biochem ENZ	1.27 M	-	-8.98 %	$ 14.8 K	USA
Exact Sciences Corporation EXAS	125 M	-	-	$ 19.8 B	USA
Fulgent Genetics FLGT	24.9 M	$ 16.31	1.75 %	$ 493 M	USA
Medpace Holdings MEDP	27.2 M	$ 410.54	4.35 %	$ 11.8 B	USA
Global Cord Blood Corporation CO	43.3 M	-	-	$ 399 M	China
Charles River Laboratories International CRL	403 M	$ 169.8	1.23 %	$ 8.42 B	USA
Guardant Health GH	39.7 M	$ 88.91	1.18 %	$ 11.1 B	USA
HTG Molecular Diagnostics HTGM	587 K	-	-20.0 %	$ 1.06 M	USA
Heska Corporation HSKA	14 M	-	-	$ 1.31 B	USA
Interpace Biosciences IDXG	425 K	$ 1.98	-2.37 %	$ 8.76 M	USA
Illumina ILMN	354 M	$ 127.88	1.95 %	$ 20.3 B	USA
National Research Corporation NRC	7.62 M	$ 17.23	-0.12 %	$ 386 M	USA
Personalis PSNL	10.9 M	$ 6.1	3.39 %	$ 361 M	USA
QIAGEN N.V. QGEN	194 M	-	-	$ 10.6 B	Niderland
Biomerica BMRA	87 K	$ 2.14	-0.47 %	$ 4.92 M	USA
ICON Public Limited Company ICLR	488 M	$ 102.17	-3.92 %	$ 8.43 B	Irlanda
Laboratory Corporation of America Holdings LH	681 M	$ 263.8	-0.43 %	$ 21.9 B	USA
Motus GI Holdings MOTS	451 K	-	-34.28 %	$ 263 K	Israel
Celcuity CELC	167 K	$ 121.03	6.58 %	$ 5.66 B	USA
Thermo Fisher Scientific TMO	1.05 B	$ 469.71	0.64 %	$ 177 B	USA
NeoGenomics NEO	36.1 M	$ 8.29	4.8 %	$ 1.06 B	USA
Neogen Corporation NEOG	119 M	$ 9.54	2.03 %	$ 2.07 B	USA
Twist Bioscience Corporation TWST	24.9 M	$ 60.94	3.55 %	$ 3.64 B	USA
Myriad Genetics MYGN	53.7 M	$ 4.78	-0.21 %	$ 443 M	USA
Natera NTRA	16.7 M	$ 203.75	1.3 %	$ 20.1 B	USA
Quest Diagnostics Incorporated DGX	570 M	$ 196.27	-1.66 %	$ 21.8 B	USA
Invitae Corporation NVTA	142 M	-	-	$ 21.2 M	USA
Organovo Holdings ONVO	266 K	-	-2.3 %	$ 19.4 M	USA
OpGen OPGN	175 K	-	-16.95 %	$ 1.54 M	USA
Waters Corporation WAT	88.1 M	$ 309.87	-0.43 %	$ 18.5 B	USA